|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.6 EUR | +5.57% |
|
+10.43% | -12.09% |
| 05-17 | Inventiva: DMC recommends continuation of study | CF |
| 05-13 | Inventiva: additional Phase 2 results in NASH | CF |
Inventiva S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 1.9 million compared to EUR 0.067 million a year ago. Net loss was EUR 55.27 million compared to EUR 29.47 million a year ago.
Basic loss per share from continuing operations was EUR 1.31 compared to EUR 0.72 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.09% | 205M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
INVENTIVA 
